|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Office |
|
2008-08-06 |
4 |
OE |
$6.46 |
$3,876 |
D/D |
600 |
9,167 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-06-30 |
4 |
A |
$103.97 |
$21,626 |
D/D |
208 |
9,190 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-09-30 |
4 |
A |
$89.74 |
$22,794 |
D/D |
254 |
9,444 |
0 |
- |
|
IMNM |
Immunome Inc. |
|
|
2024-05-21 |
4 |
B |
$13.57 |
$27,140 |
D/D |
2,000 |
9,615 |
0.01 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Office |
|
2008-08-07 |
4 |
OE |
$6.46 |
$3,230 |
D/D |
500 |
9,667 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2014-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
9,725 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2007-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,999 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-12-01 |
4 |
AB |
$9.89 |
$14,916 |
D/D |
1,500 |
10,000 |
2.81 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2010-05-24 |
4 |
S |
$8.06 |
$16,131 |
D/D |
(2,000) |
10,121 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-08-08 |
4 |
OE |
$6.46 |
$4,199 |
D/D |
650 |
10,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-25 |
4 |
AS |
$17.65 |
$44,125 |
D/D |
(2,500) |
10,695 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,923 |
10,844 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-08-11 |
4 |
OE |
$6.46 |
$3,876 |
D/D |
600 |
10,917 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-12-08 |
4 |
S |
$17.00 |
$67,988 |
D/D |
(4,000) |
10,917 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-12-12 |
4 |
B |
$10.21 |
$10,208 |
D/D |
1,000 |
11,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-01 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
11,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-03 |
4 |
S |
$38.10 |
$76,239 |
D/D |
(2,000) |
11,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-09 |
4 |
OE |
$6.46 |
$51,680 |
D/D |
8,000 |
11,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2009-03-05 |
4/A |
B |
$10.04 |
$10,039 |
D/D |
1,000 |
11,917 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-03-05 |
4 |
A |
$10.04 |
$10,039 |
D/D |
1,000 |
11,917 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2010-05-19 |
4 |
S |
$8.71 |
$13,065 |
D/D |
(1,500) |
12,121 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2006-01-03 |
4 |
B |
$10.76 |
$16,190 |
D/D |
1,500 |
12,500 |
2.81 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
12,988 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-04 |
4 |
AS |
$18.38 |
$45,962 |
D/D |
(2,500) |
13,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-04-30 |
4 |
A |
$10.93 |
$16,648 |
D/D |
1,523 |
13,440 |
0 |
- |
|
853 Records found
|
|
Page 4 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|